Reply to the letter to the editor in response to 'A real-world study of ART in France (REOLA) comparing a biosimilar rFSH against the originator according to rFSH starting dose' by S. Montenegro, C. Helwig, J.-E. Schwarze, C. Castello-Bridoux, S. Marque, M. Lispi, et al. (J Gynecol Obstet Hum Reprod. 2023;52(8):102640)
- PMID: 37573940
- DOI: 10.1016/j.jogoh.2023.102644
Reply to the letter to the editor in response to 'A real-world study of ART in France (REOLA) comparing a biosimilar rFSH against the originator according to rFSH starting dose' by S. Montenegro, C. Helwig, J.-E. Schwarze, C. Castello-Bridoux, S. Marque, M. Lispi, et al. (J Gynecol Obstet Hum Reprod. 2023;52(8):102640)
Conflict of interest statement
Declaration of Competing Interest P.Barriere received consulting fees and speaker honoraria from Gedeon Richter France. Elisangela Arbo works at Gedeon Richter France. Julian Jenkins is works at Gedeon Richter Suisse.
Comment on
-
Letter to the editor in response to 'A real-world study of ART in France (REOLA) comparing a biosimilar rFSH against the originator according to rFSH starting dose' by P. Barrière, S. Hamamah, E. Arbo, C. Avril, B. Salle, J.-L. Pouly, et al. (J Gynecol Obstet Hum Reprod. 2023;52(1):102510).J Gynecol Obstet Hum Reprod. 2023 Oct;52(8):102640. doi: 10.1016/j.jogoh.2023.102640. Epub 2023 Aug 6. J Gynecol Obstet Hum Reprod. 2023. PMID: 37549879 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
